On Tuesday, Syra Health Corp (NASDAQ: SYRA) opened higher 20.10% from the last session, before settling in for the closing price of $0.41. Price fluctuations for SYRA have ranged from $0.34 to $8.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 98.87%. Company’s average yearly earnings per share was noted -43.33% at the time writing. With a float of $7.44 million, this company’s outstanding shares have now reached $9.81 million.
Considering the fact that the conglomerate employs 162 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 11.34%, operating margin of -58.89%, and the pretax margin is -59.23%.
Syra Health Corp (SYRA) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of Syra Health Corp is 24.09%, while institutional ownership is 0.71%. The most recent insider transaction that took place on Dec 04 ’23, was worth 4,869. In this transaction CFO and COO of this company bought 4,271 shares at a rate of $1.14, taking the stock ownership to the 8,106 shares. Before that another transaction happened on Sep 12 ’24, when Company’s CFO and COO bought 5,303 for $0.38, making the entire transaction worth $2,015. This insider now owns 10,295 shares in total.
Syra Health Corp (SYRA) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -43.33% per share during the next fiscal year.
Syra Health Corp (NASDAQ: SYRA) Trading Performance Indicators
Check out the current performance indicators for Syra Health Corp (SYRA). In the past quarter, the stock posted a quick ratio of 3.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.67, a number that is poised to hit -0.21 in the next quarter
Technical Analysis of Syra Health Corp (SYRA)
Compared to the last year’s volume of 0.81 million, its volume of 0.16 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 57.39%. Additionally, its Average True Range was 0.05.
During the past 100 days, Syra Health Corp’s (SYRA) raw stochastic average was set at 10.57%, which indicates a significant decrease from 95.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 112.57% in the past 14 days, which was lower than the 128.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6113, while its 200-day Moving Average is $1.2545. Nevertheless, the first resistance level for the watch stands at $0.5212 in the near term. At $0.5523, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.6079. If the price goes on to break the first support level at $0.4345, it is likely to go to the next support level at $0.3789. Now, if the price goes above the second support level, the third support stands at $0.3478.
Syra Health Corp (NASDAQ: SYRA) Key Stats
There are currently 5,771K shares outstanding in the company with a market cap of 4.81 million. Presently, the company’s annual sales total 5,520 K according to its annual income of -2,940 K. Last quarter, the company’s sales amounted to 1,970 K and its income totaled -1,390 K.
